Any BioTech Guys that Have Looked at Moderna?
I am not a biotech person, looking at Moderna. Has any looked at Moderna as a possible long or short? Why was it USED for such an IMPORTANT pandemic? Specifically trying to get comfortable with the following qs:
-
Which of their drugs in-development are first-in-class drugs? What is generally the decision-framework behind allocating capital to these?
-
How does one think through their scientist research and your scientist-retention ratio? What is the best way to measure productivity? Is it increase (%) in R&D relative to the % # of drugs that pass onto the next phase?
-
I am looking at their teams' cost-base in relation to Pfitzer (much larger company, granted), and using your SG&A expense as a proxy for fixed costs including non R&D salaries, I see the average cost / employee is $110K compared to $73K for Pfitzer. I understand earlier years may be spent burning cash, but Moderna has been around for 10+ years now. How do I justify these to myself?
-
Related to the above note, for the senior management, how is the payout determined? What factor does R&D pipeline achievement play in that?
-
With respect to its revenue split, how should one think about it from Government Contracts, and Grant perspective, and which r assets have licensing potential i.e. ability to earn royalties?
-
Their revenue for 9M 21 was about $11.3 billion, of which 75% is in deferred revenue. What would be the cost of servicing this revenue? Is it non-material?
-
I am not a fan of DCFs, particularly over a long time frame. It's like coming up with something out of your ass when you have no idea what will transpire over the future. What's a better valuation metric to value biotech?
-
For those of you with non science backgrounds, how did you get comfortable "understanding the science"?
Let me know pls. thx
Hey Associate 1 in IB-M&A, I'm the WSO Monkey Bot...do any of these help:
More suggestions...
Fingers crossed that one of those helps you.
Dolores laboriosam qui aliquid nesciunt voluptatem culpa pariatur. Ducimus ad unde cum aut deserunt vel. Assumenda nam et temporibus facilis praesentium reprehenderit.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...